| Target and Pathway |
Top |
| Target(s) |
Cyclic ADP-ribose hydrolase 1 (CD38) |
Target Info
|
Inhibitor |
[2] |
| T-cell surface glycoprotein CD3 (CD3) |
Target Info
|
Inhibitor |
[2] |
| T-cell-specific surface glycoprotein CD28 (CD28) |
Target Info
|
Inhibitor |
[2] |
|
KEGG Pathway
|
Nicotinate and nicotinamide metabolism
|
|
Metabolic pathways
|
|
Calcium signaling pathway
|
|
Hematopoietic cell lineage
|
|
Oxytocin signaling pathway
|
|
Salivary secretion
|
|
Pancreatic secretion
|
|
Epstein-Barr virus infection
|
|
Cell adhesion molecules (CAMs)
|
|
T cell receptor signaling pathway
|
|
Intestinal immune network for IgA production
|
|
Type I diabetes mellitus
|
|
Measles
|
|
Autoimmune thyroid disease
|
|
Systemic lupus erythematosus
|
|
Rheumatoid arthritis
|
|
Allograft rejection
|
|
Graft-versus-host disease
|
|
Viral myocarditis
|
|
NetPath Pathway
|
Leptin Signaling Pathway
|
|
TCR Signaling Pathway
|
|
Panther Pathway
|
CCKR signaling map ST
|
|
T cell activation
|
|
Pathway Interaction Database
|
TCR signaling in naï
|
|
|
|
TCR signaling in naï
|
|
|
|
IL12 signaling mediated by STAT4
|
|
Reactome
|
PIP3 activates AKT signaling
|
|
Constitutive Signaling by Aberrant PI3K in Cancer
|
|
CD28 co-stimulation
|
|
CD28 dependent PI3K/Akt signaling
|
|
CD28 dependent Vav1 pathway
|
|
WikiPathways
|
Oxytocin signaling
|
|
TCR Signaling Pathway
|
|
Inflammatory Response Pathway
|
|
Host Interactions of HIV factors
|
|
PIP3 activates AKT signaling
|
|
T-Cell Receptor and Co-stimulatory Signaling
|
|
Allograft Rejection
|
|
Costimulation by the CD28 family
|
